Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Barry J. Simon

Director at ImmunityBio, Inc. (IBRX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $4.4M

Reported trades

Filed Stock Type Shares Price Value Since
Oct 6SEC IBRXImmunityBio, Inc. Sell Plan 25,0002,777,788 held (−1%) $10.75 $269K -2.2%
Jun 26SEC IBRXImmunityBio, Inc. Sell Plan 25,0002,802,788 held (−1%) $7.88 $197K +33.4%
Jun 5SEC IBRXImmunityBio, Inc. Sell Plan 23,0332,827,788 held (−1%) $7.18 $165K +46.4%
Feb 26SEC IBRXImmunityBio, Inc. Sell Plan 75,0002,850,821 held (−3%) $12.01 $901K -12.5%
Feb 24SEC IBRXImmunityBio, Inc. Sell Plan 10,0003,081,604 held (−0%) $9.25 $92K +13.6%
Feb 24SEC IBRXImmunityBio, Inc. Sell Plan 165,0002,925,821 held (−5%) $10.25 $1.7M +2.5%
Jan 21SEC IBRXImmunityBio, Inc. Sell Plan 76,9673,166,604 held (−2%) $6.54 $503K +60.7%
Jan 21SEC IBRXImmunityBio, Inc. Sell Plan 75,0003,091,604 held (−2%) $7.88 $591K +33.4%
  • Sell

    Director Barry J. Simon sold $269K of IBRX at $10.75 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Barry J. Simon sold $197K of IBRX at $7.88 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Barry J. Simon sold $165K of IBRX at $7.18 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Barry J. Simon sold $901K of IBRX at $12.01 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Barry J. Simon sold $92K of IBRX at $9.25 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Barry J. Simon sold $1.7M of IBRX at $10.25 — pre-scheduled 10b5-1 plan sale.